Most Recent
July 8, 2022
FTC Investigation into PBMs Must Focus on Rebates & Fees from Rx Manufacturers
On June 7th, the Federal Trade Commission announced an Inquiry Into Prescription Drug Middlemen Industry. The industry the FTC is referring to, are Prescription Benefit Managers, often referred to as PBMs. On principle, PBMs make…
Most Recent
May 4, 2022
Congress Should Take a New Look at T-Mobile and Sprint Merger
Joe Biden’s poll numbers are hurting, and I have taken issue with some of the more progressive goals of this Administration, but to say his first two years in office have been a failure would…